Genetic and Molecular Approaches to Drug Target Discovery for Treatment of the most Dangerous Diseases that are Rapidly Increasing Globally. Part II

Author(s): Vasily N. Sukhorukov, Alexander N. Orekhov

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 6 , 2019


Become EABM
Become Reviewer
Call for Editor

[1]
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
[2]
Paone C, Diofano F, Park D-D, Rottbauer W, Just S. Genetics of Cardiovascular Disease: Fishing for Causality. Front Cardiovasc Med 2018; 5: 60.
[3]
Hu Y-H, Zhou L, Wang S-S, et al. Methotrexate disposition in pediatric patients with acute lymphoblastic leukemia: What have we learnt from the genetic variants of drug transporters. Curr Pharm Des 2019; 25(6): 627-34.
[4]
Myasoedova VA, Sukhorukov VN, Grechko AV, et al. Inhibitors of DNA methylation and histone deacetylation as epigenetically active drugs for anticancer therapy. Curr Pharm Des 2019; 25(6): 635-41.
[5]
Uzma Zaheer, Faheem M, Qadri I, Begum N, Mathew S. Expression profile of microRNA: an emerging hallmark of cancer. Curr Pharm Des 2019; 25(6): 642-53.
[6]
Fang L, Li F, Gu C. GDF-15 is a multifunctional modulator and potential therapeutic target in cancer. Curr Pharm Des 2019; 25(6): 654-62.
[7]
Yurova K, Khaziakhmatova OG, Melaschenko ES, et al. Cellular and molecular basis of osteoblastic and vascular niches in the processes of hematopoiesis and bone remodeling (A short review of modern views). Curr Pharm Des 2019; 25(6): 663-9.
[8]
de Souza P, da Silva LM, de Andrade SF, Gasparotto Junior A.. Recent advances in knowledge of natural-derived bioactive as modulating agents of the renin-angiotensin-aldosterone system: therapeutic benefit in cardiovascular diseases. Curr Pharm Des 2019; 25(6): 670-84.
[9]
Miyauchi S, Nagai M, Dote K, et al. Visit-to-visit blood pressure variability and arterial stiffness: which came first: the chicken or the egg. Curr Pharm Des 2019; 25(6): 685-92.
[10]
Sazonova MA, Ryzhkova AI, Sinyov VV, et al. Creation of cultures containing mutations linked with cardiovascular diseases using transfection and genome editing. Curr Pharm Des 2019; 25(6): 693-9.
[11]
Zhang S, Wang Y, Cheng J, et al. Hyperuricemia and cardiovascular disease. Curr Pharm Des 2019; 25(6): 700-9.
[12]
Konstantinova EV, Chipigina NS, Shurdumova MH, Kovalenko EI, Sapozhnikov AM. Heat shock protein 70 kDa as a target for diagnostics and therapy of cardio-vascular and cerebrovascular diseases. Curr Pharm Des 2019; 25(6): 710-4.
[13]
Lan H-Y, Zhao B, Shen Y-L, et al. Phytochemistry, pharmacological activities, toxicity and clinical application of Momordica cochinchinensis. Curr Pharm Des 2019; 25(6): 715-28.
[14]
Gudasheva TA, Povarnina P, Tarasiuk AV, Seredenin SB. The low molecular weight brain derived neurotrophic factor mimetics with antidepressant-like activity. Curr Pharm Des 2019; 25(6): 729-37.
[15]
Fathinezhad Z, Sewell RD, Lorigooini Z, Rafieian-Kopaei M. Depression and treatment with effective herbs. Curr Pharm Des 2019; 25(6): 738-45.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 6
Year: 2019
Page: [625 - 626]
Pages: 2
DOI: 10.2174/138161282506190516100854

Article Metrics

PDF: 23
HTML: 4
PRC: 1